D05.12 Intraductal carcinoma in situ of left breast

Name of the Condition

• Intraductal carcinoma in situ of left breast
• Often referred to as Ductal Carcinoma In Situ (DCIS)

Summary

Intraductal carcinoma in situ (DCIS) is a non-invasive breast cancer where abnormal cells are contained within the milk ducts of the left breast. It is considered the earliest form of breast cancer and is typically localized, with no spread to surrounding tissues.

Causes

The exact cause of DCIS is not fully understood, but it involves genetic mutations in the DNA of ductal cells in the breast. These mutations lead to uncontrolled cell growth while remaining confined to the ducts.

Risk Factors

• Age: More common in women over 50.
• Family history of breast cancer.
• Genetic mutations such as BRCA1 and BRCA2.
• Prolonged exposure to estrogen.
• A previous history of breast conditions like atypical hyperplasia.

Symptoms

• DCIS often has no signs or symptoms.
• It may occasionally present as a lump or nipple discharge, but such occurrences are rare.

Diagnosis

Mammography is the primary tool for diagnosing DCIS, often revealing microcalcifications. A biopsy is typically performed to examine tissue samples under a microscope and confirm the diagnosis.

Treatment Options

• Surgery: Lumpectomy or mastectomy, depending on the extent of DCIS.
• Radiation therapy often follows surgery to eliminate any remaining abnormal cells.
• Hormonal therapy may be considered if the cancer is hormone receptor-positive.

Prognosis and Follow-Up

DCIS has an excellent prognosis when treated early, with low recurrence rates. Regular follow-up, including mammograms and clinical exams, is recommended to monitor for recurrence.

Complications

• Potential for progression to invasive breast cancer if left untreated.
• Surgical complications, such as infection or scarring, may occur.
• Radiation therapy can cause skin irritation or fatigue.

Lifestyle & Prevention

• Maintain a healthy weight and engage in regular physical activity.
• Limit alcohol consumption.
• Discuss hormone replacement therapy with a healthcare provider, as it may increase risk.
• Perform regular breast self-exams and adhere to screening guidelines.

When to Seek Professional Help

• If a new lump or change in breast tissue is noticed.
• If nipple discharge (especially bloody) occurs.
• If mammogram results indicate abnormalities.

Tips for Medical Coders

• Use D05.12 for intraductal carcinoma in situ specifically of the left breast.
• Ensure documentation specifies the breast laterality (left) and confirms the diagnosis as in situ.
• Verify that the condition is non-invasive and confined to the ducts to avoid miscoding.